This week I had a great conversation with Russ Peloquin, Managing Partner of LifeSci Catalyst Partners. We dive into Russ's unique journey from aspiring exterminator (yes, you read that right!) to leading life science entrepreneur, discussing his extensive experience in commercialization, mergers, and acquisitions. Russ shares invaluable insights on the importance of marketing, fundraising strategies for biotech startups, the phases of taking a company from idea to commercialization, and the critical steps toward securing regulatory approvals. We also touch on the intersection of genome sequencing, blockchain, and AI, exploring how this convergence is set to democratize and capitalize on personal DNA. Whether you're new to biotech or an industry veteran, this episode offers a wealth of knowledge and practical advice on navigating the complex landscape of life sciences and startups. Connect with Russ on LinkedIn! https://www.linkedin.com/in/russ-peloquin/ Learn more about LifeSci Catalyst Partners! https://www.lifescicatalyst.com/ Get Russ's recommended book! Freakonomics: https://geni.us/3qZlQA _________________________________________________________________________ ✔️Subscribe to our Mailing List for weekly podcast drops and industry news (we promise no spam!) https://buildingbiotechs.beehiiv.com/ Follow us on Apple, Spotify, or wherever you love to listen. 👉 https://apple.co/3EDuZvA 👉 https://spoti.fi/48bs3nq Stay connected with us: 🌐 Website: https://buildingbiotechspodcast.com/ 💼 LinkedIn: [https://www.linkedin.com/company/building-biotechs-podcast/](https://www.linkedin.com/company/building-biotechs-podcast/?viewAsMember=true) 🎙️Check out our sister podcast, Biotech Career Coach: https://biotechcareercoach.com/ Follow and Connect with Carina on LinkedIn: https://www.linkedin.com/in/cclingman/ In need of Fractional Talent Acquisition or Recruiting help? Reach out! info@recruitomics.com _________________________________________________________________________ 00:00 Introduction and Early Aspirations 02:04 Journey into Medical Sales 03:37 Marketing and Commercialization Insights 05:31 Navigating Early-Stage Startups 08:39 Fundraising Strategies for Biotech Startups 15:00 Acquisitions and Exits 22:39 The Intersection of Genome Sequencing, Blockchain, and AI 29:49 Future Goals and Recommendations 31:47 Closing Remarks and Contact Information

This week I chatted with Renee Williams, Founder and Managing Partner at Williams Biotech Consulting. Renee is a seasoned fractional Chief Business Officer (CBO) for small and growing biotechnology companies. Renee shares her career path, insights into helping biotech startups secure funding and navigate partnerships, and the importance of adaptable strategies in a constantly evolving market. From term sheet negotiation to pitch deck reframes, Renee offers valuable advice and lessons for small companies. We also dissect her engagement tactics during major conferences like JP Morgan and the essential factors for biotech success. Check out the full episode: https://buildingbiotechspodcast.com/episode/53 ✔️Subscribe to our Mailing List for weekly podcast drops and industry news (we promise no spam!) https://buildingbiotechs.beehiiv.com/ Follow us on Apple, Spotify, or wherever you love to listen. 👉 https://apple.co/3EDuZvA 👉 https://spoti.fi/48bs3nq Stay connected with us: 🌐 Website: https://buildingbiotechspodcast.com/ 💼 LinkedIn: https://www.linkedin.com/company/building-biotechs-podcast/ 🎙️Check out our sister podcast, Biotech Career Coach: https://biotechcareercoach.com/ Follow and Connect with Carina on LinkedIn: https://www.linkedin.com/in/cclingman/ In need of Fractional Talent Acquisition or Recruiting help? Reach out! info@recruitomics.com

This week, I spoke with Natalie Nairn, co-founder and CEO of Cyclera Therapeutics. Natalie is also a Termeer Fellow, and listeners of this podcast know how much I love the Termeer Foundation. We discuss her transition from chemical engineering to biomedical applications. She describes her unexpected path into the fun and volatile startup space, which led to her founding Cyclera. Natalie explains the importance of focusing in biotech development, the promising applications of Cyclera's technology in CNS therapeutics, and the challenges and opportunities in the current funding landscape. She also highlights the value of the Termeer fellowship in her career, the contrast between Boston and Seattle's biotech scenes, and the essential aspects of leadership and team cohesion. Finally, Natalie discusses her future goals for Cyclera and offers valuable advice for aspiring biotech founders. Check out the full episode: https://buildingbiotechspodcast.com/episode/52 ✔️Subscribe to our Mailing List for weekly podcast drops and industry news (we promise no spam!) https://buildingbiotechs.beehiiv.com/ Follow us on Apple, Spotify, or wherever you love to listen. 👉 https://apple.co/3EDuZvA 👉 https://spoti.fi/48bs3nq Stay connected with us: 🌐 Website: https://buildingbiotechspodcast.com/ 💼 LinkedIn: https://www.linkedin.com/company/building-biotechs-podcast/ 🎙️Check out our sister podcast, Biotech Career Coach: https://biotechcareercoach.com/ Follow and Connect with Carina on LinkedIn: https://www.linkedin.com/in/cclingman/ In need of Fractional Talent Acquisition or Recruiting help? Reach out! info@recruitomics.com

Eva Quinn, Senior HR Business Partner at Higher EQ, shared her consulting journey in this episode. As an HR consultant, Eva may step in for a specific project, and the culmination of her work often results in two scenarios. Ideally, she aims to pave the way for a permanent HR hire. Alternatively, Eva steps in for specific projects—hiring, performance reviews, coaching—providing tailored solutions for the diverse needs of her clients. Get more insights from Eva on strategic HR practices! Check out the full episode. ___________________________________________________________ Building Biotechs is a podcast by Recruitomics Consulting https://www.recruitomics.com/buildingbiotechspodcast Follow us on Apple, Spotify, or wherever you love to listen. 👉 https://apple.co/3EDuZvA 👉 https://spoti.fi/48bs3nq

In this episode, Lynn Walder, Executive Management Partner at LabCentral, identifies a crucial factor: leadership communication. Lynn emphasizes the impact of poor communication on a company's success. Without clear and consistent communication frameworks from leadership, both behaviorally and strategically, the risk to the company's scaling and sustainability increases significantly. Get more leadership and communication wisdom with Lynn in the full episode! ___________________________________________________________ Building Biotechs is a podcast by Recruitomics Consulting https://www.recruitomics.com/buildingbiotechspodcast Follow us on Apple, Spotify, or wherever you love to listen. 👉 https://apple.co/3EDuZvA 👉 https://spoti.fi/48bs3nq

This week I chatted with Renee Williams, Founder and Managing Partner at Williams Biotech Consulting. Renee is a seasoned fractional Chief Business Officer (CBO) for small and growing biotechnology companies. Renee shares her career path, insights into helping biotech startups secure funding and navigate partnerships, and the importance of adaptable strategies in a constantly evolving market. From term sheet negotiation to pitch deck reframes, Renee offers valuable advice and lessons for small companies. We also dissect her engagement tactics during major conferences like JP Morgan and the essential factors for biotech success. Connect with Renee in LinkedIn: https://www.linkedin.com/in/reneewilliams-chemist/ _________________________________________________________________________ ✔️Subscribe to our Mailing List for weekly podcast drops and industry news (we promise no spam!) https://buildingbiotechs.beehiiv.com/ Follow us on Apple, Spotify, or wherever you love to listen. 👉 https://apple.co/3EDuZvA 👉 https://spoti.fi/48bs3nq Stay connected with us: 🌐 Website: https://buildingbiotechspodcast.com/ 💼 LinkedIn: [https://www.linkedin.com/company/building-biotechs-podcast/](https://www.linkedin.com/company/building-biotechs-podcast/?viewAsMember=true) 🎙️Check out our sister podcast, Biotech Career Coach: https://biotechcareercoach.com/ Follow and Connect with Carina on LinkedIn: https://www.linkedin.com/in/cclingman/ In need of Fractional Talent Acquisition or Recruiting help? Reach out! info@recruitomics.com _________________________________________________________________________ 00:00 Introduction and Childhood Dreams 01:19 The Power of Dressing the Part 01:49 Career Path and Consulting Firm 03:20 Role of a Fractional CBO 04:03 Navigating Startup Challenges 06:07 Crafting Effective Pitch Decks 08:32 Big Pharma vs. Biotech Mentality 16:01 The Importance of a Strong Team in Biotech 16:20 Approaching Pharma and Corporate Venture Capital 17:20 Strategies for Biotech Companies to Gain Traction 18:24 Types of Biotech CEOs and Their Approaches 21:02 Navigating Conferences and Networking 27:09 Future Goals and Aspirations 28:59 Book Recommendations and Closing Thoughts

This week I had a fun conversation with Jason Cordiero, Chief Operating and Innovation Officer at MassBio. We dissect MassBio's newly announced five-year strategic plan that includes a multi-pronged set of initiatives aimed at advancing the biotech industry. From supporting early-stage startups to advocating for policy changes and fostering talent development, Jason details the excellent resources available and in development. Whether you're based in Massachusetts or global, this session provides valuable information on how MassBio is working to catalyze innovation and growth in biotech, and how you can leverage these opportunities. Check out the full episode: https://buildingbiotechspodcast.com/episode/48 ✔️Subscribe to our Mailing List for weekly podcast drops and industry news (we promise no spam!) https://buildingbiotechs.beehiiv.com/ Follow us on Apple, Spotify, or wherever you love to listen. 👉 https://apple.co/3EDuZvA 👉 https://spoti.fi/48bs3nq Stay connected with us: 🌐 Website: https://buildingbiotechspodcast.com/ 💼 LinkedIn: https://www.linkedin.com/company/building-biotechs-podcast/ 🎙️Check out our sister podcast, Biotech Career Coach: https://biotechcareercoach.com/ Follow and Connect with Carina on LinkedIn: https://www.linkedin.com/in/cclingman/ In need of Fractional Talent Acquisition or Recruiting help? Reach out! info@recruitomics.com

This week, I spoke with Natalie Nairn, Co-founder and CEO of Cyclera Therapeutics. Natalie is also a Termeer Fellow, and listeners of this podcast know how much I love the Termeer Foundation. We discuss her transition from chemical engineering to biomedical applications. She describes her unexpected path into the fun and volatile startup space, which led to her founding Cyclera. Natalie explains the importance of focusing in biotech development, the promising applications of Cyclera's technology in CNS therapeutics, and the challenges and opportunities in the current funding landscape. She also highlights the value of the Termeer fellowship in her career, the contrast between Boston and Seattle's biotech scenes, and the essential aspects of leadership and team cohesion. Finally, Natalie discusses her future goals for Cyclera and offers valuable advice for aspiring biotech founders. _________________________________________________________________________ ✔️Subscribe to our Mailing List for weekly podcast drops and industry news (we promise no spam!) https://buildingbiotechs.beehiiv.com/ Follow us on Apple, Spotify, or wherever you love to listen. 👉 https://apple.co/3EDuZvA 👉 https://spoti.fi/48bs3nq Stay connected with us: 🌐 Website: https://buildingbiotechspodcast.com/ 💼 LinkedIn: [https://www.linkedin.com/company/building-biotechs-podcast/](https://www.linkedin.com/company/building-biotechs-podcast/?viewAsMember=true) 🎙️Check out our sister podcast, Biotech Career Coach: https://biotechcareercoach.com/ Follow and Connect with Carina on LinkedIn: https://www.linkedin.com/in/cclingman/ In need of Fractional Talent Acquisition or Recruiting help? Reach out! info@recruitomics.com _________________________________________________________________________ 00:00 Introduction and Early Aspirations 00:33 Journey into Biomedical Engineering 01:19 First Startup Experience 03:40 Founding Cyclera 05:02 Focus on CNS Therapeutics 13:35 Challenges and Strategies in Biotech 15:39 The Termeer Foundation Fellowship 21:26 Biotech Networks: Boston vs. Seattle 26:50 Future of Cyclera and Personalized Medicine 32:45 Conclusion and Final Thoughts